Natera, Inc. (NTRA)
327.72
-4.31
(-1.30%)
USD |
NASDAQ |
Aug 24, 16:00
327.00
-0.72
(-0.22%)
After-Hours: 05:40
Natera Shareholders Equity (Quarterly) : 1.821B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.821B |
| March 31, 2026 | 1.774B |
| December 31, 2025 | 1.712B |
| September 30, 2025 | 1.252B |
| June 30, 2025 | 1.246B |
| March 31, 2025 | 1.240B |
| December 31, 2024 | 1.195B |
| September 30, 2024 | 878.52M |
| June 30, 2024 | 836.52M |
| March 31, 2024 | 794.11M |
| December 31, 2023 | 765.33M |
| September 30, 2023 | 784.66M |
| June 30, 2023 | 596.15M |
| March 31, 2023 | 650.57M |
| December 31, 2022 | 705.74M |
| September 30, 2022 | 361.62M |
| June 30, 2022 | 444.58M |
| March 31, 2022 | 542.34M |
| December 31, 2021 | 653.30M |
| September 30, 2021 | 759.02M |
| June 30, 2021 | 299.11M |
| March 31, 2021 | 372.44M |
| December 31, 2020 | 486.24M |
| Date | Value |
|---|---|
| September 30, 2020 | 536.00M |
| June 30, 2020 | 304.27M |
| March 31, 2020 | 258.93M |
| December 31, 2019 | 278.71M |
| September 30, 2019 | 84.69M |
| June 30, 2019 | 93.09M |
| March 31, 2019 | 4.986M |
| December 31, 2018 | 32.16M |
| September 30, 2018 | 56.57M |
| June 30, 2018 | -22.04M |
| March 31, 2018 | -3.876M |
| December 31, 2017 | 25.42M |
| September 30, 2017 | 30.18M |
| June 30, 2017 | 50.91M |
| March 31, 2017 | 73.67M |
| December 31, 2016 | 106.48M |
| September 30, 2016 | 140.31M |
| June 30, 2016 | 163.82M |
| March 31, 2016 | 181.60M |
| December 31, 2015 | 184.76M |
| September 30, 2015 | 206.06M |
| June 30, 2015 | 42.81M |
| March 31, 2015 | 60.69M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Guardant Health, Inc. | -222.87M |
| CareDx, Inc. | 425.60M |
| Myriad Genetics, Inc. | 303.90M |
| BioRestorative Therapies, Inc. | 3.026M |
| Exagen, Inc. | 12.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.657B |
| Total Liabilities (Quarterly) | 836.00M |
| Debt to Equity Ratio | 0.1309 |
| Current Ratio | 2.999 |
| Net Debt Paydown Yield | -0.02% |